John Towns
Advertisement
John Towns is the senior director of global CMC regulatory affairs at Eli Lilly and Company. Towns is also the chair of the Quality by Design Working Group of the PhRMA Biologics and Biotechnology Leadership Committee
Articles by John Towns
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Emerging siRNA Platform Offers New Metabolic Disorder Therapies
2
Implementing Automation and Flexible Design for Allogeneic Manufacturing
3
New Lymphoma Indication for CAR T-Cell Therapy Shapes Pipeline
4
Biocapacitance as a PAT Tool: Real-Time Biomass Monitoring for Upstream Bioprocessing
5
